Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Fik-1) in ischemic skeletal muscle and its regeneration

American Journal of Pathology

Volumn 160, Issue 4, 2002, Pages 1393-1403

  Rissanen, Tuomas T ^a   Vajanto, Ismo ^a   Hiltunen, Mikko O ^a   Rutanen, Juha ^a   Kettunen, Mikko I ^a   Niemi, Mari ^a   Leppänen, Pia ^a   Turunen, Mikko P ^a   Markkanen, Johanna E ^a   Arve, Katja ^a   Alhava, Esko ^a,b   Kauppinen, Risto A ^a   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MUSCLE ATROPHY; MUSCLE ISCHEMIA; MUSCLE REGENERATION; MYOTUBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; SKELETAL MUSCLE;

EID: 0036105785     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62566-7     Document Type: Article

References (45)

1. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
2. Vascular endothelial growth factor is a secreted angiogenic mitogen
3. Molecular and biological properties of vascular endothelial growth factor
4. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
5. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for FIk-1/KDR activation
6. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
7. Analysis of biological effects and signaling properties of Fit-1 and KDR: A reassessment using novel highly receptor-specific VEGF mutants
8. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
9. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Fit-1, but not FIk-1/KDR, is up-regulated by hypoxia
10. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
11. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
12. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
13. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
14. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - On the way to the clinic
15. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L
16. Hypoxia-inducible factor 1 alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
17. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells
18. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia
19. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro
20. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
21. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development
22. Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells
23. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia
24. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
25. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects
26. Cardiovascular gene therapy
27. Enhanced revascularization of the ischemic limb by angiogenic therapy
28. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions
29. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta
30. Detection of mRNA on paraffin embedded material of the central nervous system with DIG-labeled RNA probes
31. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction, with necrosis-specific and extracellular nonspecific contrast media
32. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
33. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
34. Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway
35. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
36. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
37. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
38. Muscle regeneration: Molecular aspects and therapeutic implications
39. Growth factors improve muscle healing in vivo
40. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle
41. Homologous up-regulation of KDR/FIk-1 receptor expression by vascular endothelial growth factor in vitro
42. VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells
43. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo
44. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B
45. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells